Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P S Schein

Showing results (211-220 of 218) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 218 results.
Annals of Internal Medicine|October 1, 1980
5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancerJ S MacDonald, P S Schein, P V Woolley, et al.
Cancer Clinical Trials|January 1, 1981
Animal toxicology for early clinical trials with anticancer agentsM Rozencweig, D D Von Hoff, M J Staquet, et al.
Cancer Treatment Reports|June 1, 1986
Phase II trials of 5-FU, doxorubicin, and cisplatin in advanced, measurable adenocarcinoma of the lung and stomachE L Cazap, C Gisselbrecht, F P Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1990
A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer GroupR C Coombes, P S Schein, C E Chilvers, et al.
Cancer Treatment Reports|July 1, 1984
Phase II trial of PCNU in advanced renal cell carcinoma and malignant melanomaJ H Harvey, F P Smith, M W Bowers, et al.
The British Journal of Cancer. Supplement|March 1, 1975
Percutaneous liver biopsy, peritoneoscopy and laparotomy: an assessment of relative merits in the lymphomataB A Chabner, R E Johnson, P B Chretien, et al.
Anti-Cancer Drug Design|November 1, 1986
Cellular pharmacology of mu-[1,2-bis(diphenylphosphino)ethane]bis[(1-thio-beta-D-gluco pyranosato-S)gold(I)]: a novel antitumor agentC K Mirabelli, B D Jensen, M R Mattern, et al.
Cancer|July 1, 1978
Randomized phase II clinical trial of adriamycin, methotrexate, and actinomycin-D in advanced measurable pancreatic carcinoma: a Gastrointestinal Tumor Study Group ReportP S Schein, P T Lavin, C G Moertel, et al.
Pageof 22

Showing results (211-220 of 218) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 218 results.
Annals of Internal Medicine|October 1, 1980
5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancerJ S MacDonald, P S Schein, P V Woolley, et al.
Cancer Clinical Trials|January 1, 1981
Animal toxicology for early clinical trials with anticancer agentsM Rozencweig, D D Von Hoff, M J Staquet, et al.
Cancer Treatment Reports|June 1, 1986
Phase II trials of 5-FU, doxorubicin, and cisplatin in advanced, measurable adenocarcinoma of the lung and stomachE L Cazap, C Gisselbrecht, F P Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1990
A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer GroupR C Coombes, P S Schein, C E Chilvers, et al.
Cancer Treatment Reports|July 1, 1984
Phase II trial of PCNU in advanced renal cell carcinoma and malignant melanomaJ H Harvey, F P Smith, M W Bowers, et al.
The British Journal of Cancer. Supplement|March 1, 1975
Percutaneous liver biopsy, peritoneoscopy and laparotomy: an assessment of relative merits in the lymphomataB A Chabner, R E Johnson, P B Chretien, et al.
Anti-Cancer Drug Design|November 1, 1986
Cellular pharmacology of mu-[1,2-bis(diphenylphosphino)ethane]bis[(1-thio-beta-D-gluco pyranosato-S)gold(I)]: a novel antitumor agentC K Mirabelli, B D Jensen, M R Mattern, et al.
Cancer|July 1, 1978
Randomized phase II clinical trial of adriamycin, methotrexate, and actinomycin-D in advanced measurable pancreatic carcinoma: a Gastrointestinal Tumor Study Group ReportP S Schein, P T Lavin, C G Moertel, et al.
Pageof 22